This in vivo study showed that, in contrast to propofol, sevoflurane exposure resulted in bigger ex vivo tumour size, shorter survival time, higher HGF and HIF1α expression, and lower TIMP-2 expression than propofol injection. This evidence concerns the gene HGF and neoplasm.